Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: BIOINTRON BIOLOGICAL USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-19 to 2023-12-29
Current total value of award: $16345.5
Description: ANTIBODY EXPRESSION SERVICE